Literature DB >> 8234021

Comparative study of vascular relaxation and receptor binding by PACAP and VIP.

M Huang1, H Shirahase, O P Rorstad.   

Abstract

The pharmacological properties of the pituitary adenylate cyclase activating peptides (PACAPs) and vasoactive intestinal peptide (VIP) were compared using: (i) relaxation of vascular and gastric smooth muscle in vitro, and (ii) radioligand binding to membrane preparations of a variety of tissues. Vasoactive intestinal peptide and PACAP-27 were similarly potent in relaxing rat mesenteric arteries, porcine coronary arteries, and rat gastric smooth muscle, whereas PACAP-38 was either more or less potent than the other two peptides depending on the tissue model. Cross-desensitization to relaxation and radioligand binding studies of porcine coronary arteries suggested that VIP and the PACAPs interact with a common receptor in this tissue. A PACAP-preferring receptor with low affinity for VIP was identified in radioligand binding studies of rat brain and anterior pituitary. A second, nonselective, receptor that binds VIP and both PACAPs with high affinity was observed in preparations of rat and porcine arteries and rat lung, liver, brain, and anterior pituitary.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234021     DOI: 10.1016/0196-9781(93)90109-t

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  The role of joint nerves and mast cells in the alteration of vasoactive intestinal peptide (VIP) sensitivity during inflammation progression in rats.

Authors:  Jason J McDougall; Ali Kursat Barin
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

2.  Central effects of pituitary adenylate cyclase activating polypeptide (PACAP) on gastric motility and emptying in rats.

Authors:  M Ozawa; M Aono; M Moriga
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

3.  Pituitary adenylate cyclase-activating polypeptide (PACAP) induces relaxations of peripheral and cerebral arteries, which are differentially impaired by aging.

Authors:  Zoltan Vamos; Ivan Ivic; Peter Cseplo; Gabor Toth; Andrea Tamas; Dora Reglodi; Akos Koller
Journal:  J Mol Neurosci       Date:  2014-06-19       Impact factor: 3.444

4.  Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat.

Authors:  G Bertrand; R Puech; Y Maisonnasse; J Bockaert; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

5.  VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model.

Authors:  Angela Storka; Bernhard Burian; Gerhard Führlinger; Breanna Clive; Terri Sun; Richard Crevenna; Andrea Gsur; Wilhelm Mosgöller; Michael Wolzt
Journal:  J Transl Med       Date:  2013-05-07       Impact factor: 5.531

6.  VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in female mice.

Authors:  Ivan Ivic; Marta Balasko; Balazs D Fulop; Hitoshi Hashimoto; Gabor Toth; Andrea Tamas; Tamas Juhasz; Akos Koller; Dora Reglodi; Margit Solymár
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.